Publisher Correction: Sensory attenuation in Parkinson’s disease is related to disease severity and dopamine dose
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Publisher Correction: Sensory attenuation in Parkinson’s disease is related to disease severity and dopamine dose ; volume:8 ; number:1 ; day:22 ; month:11 ; year:2018 ; pages:1-2 ; date:12.2018
Scientific reports ; 8, Heft 1 (22.11.2018), 1-2, 12.2018
- Classification
-
Allgemeines, Wissenschaft
- Creator
-
Wolpe, Noham
Zhang, Jiaxiang
Nombela, Cristina
Ingram, James N.
Wolpert, Daniel M.
Rowe, James B.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-35439-8
- URN
-
urn:nbn:de:101:1-2019010713242422570332
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wolpe, Noham
- Zhang, Jiaxiang
- Nombela, Cristina
- Ingram, James N.
- Wolpert, Daniel M.
- Rowe, James B.
- SpringerLink (Online service)
Other Objects (12)
Sensory attenuation in Parkinson’s disease is related to disease severity and dopamine dose
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Schizotypy in Parkinson’s disease predicts dopamine-associated psychosis
Dopamine boosts intention and action awareness in Parkinson’s disease
Role of dopamine in the pathophysiology of Parkinson’s disease
Mapping neuromodulatory systems in Parkinson’s disease: lessons learned beyond dopamine
Acquired dysregulation of dopamine homeostasis reproduces features of Parkinson’s disease
Autonomic failure in Parkinson’s disease is associated with striatal dopamine deficiencies
The role of tyrosine hydroxylase–dopamine pathway in Parkinson’s disease pathogenesis
Predictors of dopamine dysregulation syndrome in patients with early Parkinson’s disease
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
Dopamine modification of glycolytic enzymes impairs glycolysis: possible implications for Parkinson’s disease
Sensory attenuation in Parkinson’s disease is related to disease severity and dopamine dose
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Schizotypy in Parkinson’s disease predicts dopamine-associated psychosis
Dopamine boosts intention and action awareness in Parkinson’s disease
Role of dopamine in the pathophysiology of Parkinson’s disease
Mapping neuromodulatory systems in Parkinson’s disease: lessons learned beyond dopamine
Acquired dysregulation of dopamine homeostasis reproduces features of Parkinson’s disease
Autonomic failure in Parkinson’s disease is associated with striatal dopamine deficiencies
The role of tyrosine hydroxylase–dopamine pathway in Parkinson’s disease pathogenesis
Predictors of dopamine dysregulation syndrome in patients with early Parkinson’s disease
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
Dopamine modification of glycolytic enzymes impairs glycolysis: possible implications for Parkinson’s disease
Sensory attenuation in Parkinson’s disease is related to disease severity and dopamine dose
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Schizotypy in Parkinson’s disease predicts dopamine-associated psychosis
Dopamine boosts intention and action awareness in Parkinson’s disease
Role of dopamine in the pathophysiology of Parkinson’s disease
Mapping neuromodulatory systems in Parkinson’s disease: lessons learned beyond dopamine
Acquired dysregulation of dopamine homeostasis reproduces features of Parkinson’s disease
Autonomic failure in Parkinson’s disease is associated with striatal dopamine deficiencies
The role of tyrosine hydroxylase–dopamine pathway in Parkinson’s disease pathogenesis
Predictors of dopamine dysregulation syndrome in patients with early Parkinson’s disease
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease